This is the authors' abstract. We don't add key points for this paper.
Our previous findings demonstrated that naïve B cells elicit suppressive CD4 + regulatory T (Treg) cells, named as Treg‐of‐B cells. However, the capability of antigen‐specific B cells in that process remains unclear. Using ovalbumin (OVA) as a model antigen, the present study showed that B cells from OVA‐immunised mice decreased that ability. Instead, OVA‐activated OVA‐specific (OB1) B cells induced effector‐like T‐of‐OB1 cells without regulatory function. Phenotypically, Treg‐of‐B cells reduced the production of interferon (IFN)‐γ, interleukin (IL)‐17 and IL‐2 and expressed CD62L, PD1 and endothelial cell adhesion molecule 1 (PECAM1). Functionally, adoptive transfer of Treg‐of‐B cells significantly attenuated Th1 cell‐mediated delayed‐type hypersensitivity (DTH) responses and inhibited IFN‐γ‐producing Th1 cells, while T‐of‐OB1 cells did not. Mechanistically, activated antigen‐specific B cells increased the expression of costimulatory molecules and promoted higher T cell activation, contributing to effector T cell phenotype. Conversely, Treg‐of‐B cells exhibited lower T cell activation, possibly mediated through the expression of PECAM1, Dusp2, Dusp5, Ptpn7, Ptpn22 and Ms4a4b . These findings suggest that non‐antigen‐specific B cells elicit CD4 + Treg cells, potentially via attenuating T cell activation, whereas that capacity is absent in antigen‐specific B cells. This distinction underscores the critical role of B cell antigen specificity in immune regulation and inflammation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chien et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: